EXACT Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
EXACT Therapeutics has a total shareholder equity of NOK45.1M and total debt of NOK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NOK61.3M and NOK16.2M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | n/a |
| Cash | kr46.43m |
| Equity | kr45.10m |
| Total liabilities | kr16.22m |
| Total assets | kr61.32m |
Recent financial health updates
Is EXACT Therapeutics (OB:EXTX) In A Good Position To Invest In Growth?
Apr 20
We Think EXACT Therapeutics (OB:EXTX) Can Afford To Drive Business Growth
Sep 07We're Hopeful That EXACT Therapeutics (OB:EXTX) Will Use Its Cash Wisely
May 06Here's Why We're Watching EXACT Therapeutics' (OB:EXTX) Cash Burn Situation
Dec 30Companies Like EXACT Therapeutics (OB:EXTX) Are In A Position To Invest In Growth
Sep 15EXACT Therapeutics (OB:EXTX) Is In A Good Position To Deliver On Growth Plans
Jan 31Recent updates
Is EXACT Therapeutics (OB:EXTX) In A Good Position To Invest In Growth?
Apr 20We Think EXACT Therapeutics (OB:EXTX) Can Afford To Drive Business Growth
Sep 07We're Hopeful That EXACT Therapeutics (OB:EXTX) Will Use Its Cash Wisely
May 06Here's Why We're Watching EXACT Therapeutics' (OB:EXTX) Cash Burn Situation
Dec 30Companies Like EXACT Therapeutics (OB:EXTX) Are In A Position To Invest In Growth
Sep 15EXACT Therapeutics (OB:EXTX) Is In A Good Position To Deliver On Growth Plans
Jan 31We Think EXACT Therapeutics (OB:EXTX) Can Afford To Drive Business Growth
Aug 21We're Not Very Worried About EXACT Therapeutics' (OB:EXTX) Cash Burn Rate
May 21Financial Position Analysis
Short Term Liabilities: EXTX's short term assets (NOK55.9M) exceed its short term liabilities (NOK15.5M).
Long Term Liabilities: EXTX's short term assets (NOK55.9M) exceed its long term liabilities (NOK732.0K).
Debt to Equity History and Analysis
Debt Level: EXTX is debt free.
Reducing Debt: EXTX has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EXTX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: EXTX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 8.8% each year